Verita Precedent Client Login Request Proposal
Kurtzman Carson Consultants, LLC (KCC) has rebranded as Verita Global. All existing KCC URLs and email addresses will be automatically redirected. KCC will remain as a legal entity as we make this transition.

KCC Precedent Search Options

KCC's Corporate Restructuring Court Documents Search provides access to thousands of historical court documents located on KCC public access websites. Please use the form below to refine and maximize search results.

For information about the data provided, please review the Disclaimer statement.

(Search All)
(Search All)
(Search All)
  • (Search All)
  • >1
  • >50
  • >100

Disclaimer


Confirmation of Plan:

Please take notice that on September 5, 2024, the Court entered the Order Approving the Debtors’ Amended Disclosure Statement and Confirming the Fifth Amended Joint Plan of Liquidation of Eiger Biopharmaceuticals, Inc. and its Debtor Affiliates [Docket No. 639].

Furthermore, the effective date occurred on September 30, 2024 per the Notice of Occurrence of Effective Date of Fifth Amended Joint Plan of Liquidation of Eiger Biopharmaceuticals, Inc. and its Debtor Affiliates Pursuant to Chapter 11 of the Bankruptcy Code [Docket No. 685].

General Information:

On April 1, 2024, each of the 5 Debtors filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”). The cases are pending joint administration under Case No. 24-80040, before the Honorable Stacey G. Jernigan, in the United States Bankruptcy Court for the Northern District of Texas (the “Bankruptcy Court”).

For additional information, please call (888) 733-1544 (U.S./Canada) or (310) 751-2638 (International) or click here to submit an inquiry.

Common Stock Notice

Important - Attention Direct and Indirect Holders of, and Prospective Holders of, Common Stock Issued By Eiger Biopharmaceuticals, Inc.:

Pursuant to the Order Approving Notification and Hearing Procedures for Certain Transfers of and Declarations of Worthlessness With Respect to Common Stock [Docket No. 82], the restrictions, notification requirements, and/or other procedures contained in the below notice apply to all transfers of, or declarations of worthlessness with respect to, common stock of the Debtors.

  • Notice of Disclosure Procedures Applicable to Certain Holders of Common Stock and Disclosure Procedures for Transfers of and Declarations of Worthlessness With Respect to Common Stock

    • Important Dates, Deadlines & Documents Show All Dates

    Notice of Effective Date

    September 30, 2024

    Save to Calendar

    Combined Hearing Notice

    August 30, 2024
    (4:00 p.m. (CT))

    Save to Calendar

    Bar Date Notice
    Bar Date Order

    September 30, 2024
    (4:00 p.m. (CT))

    Save to Calendar

    Bar Date Notice
    Bar Date Order

    July 22, 2024
    (4:00 p.m. (CT))

    Save to Calendar

    Amended Agenda
    Notice of Hearing (Bar Date)
    Bar Date Motion
    Notice of Hearing (Avexitide Sale)
    Revised Notice of Sale Hearing

    June 26, 2024
    (1:30 p.m. (CT))

    Save to Calendar

    Notice of Chapter 11 Bankruptcy Case

    May 13, 2024
    (1:30 p.m. (CT))

    Save to Calendar

    Notice of Hearing

    May 7, 2024
    (1:30 p.m. CT)

    Save to Calendar

    Notice of Hearing
    First Day Motions

    April 23, 2024
    (9:30 a.m. CT)

    Save to Calendar

    Agenda for Hearing Scheduled For April 3, 2024
    Notice of Emergency Hearing for April 3, 2024

    April 3, 2024
    (1:30 p.m. CT)

    Save to Calendar

    April 1, 2024

    Save to Calendar

    Debtors

    Debtor Name
    Debtor Case Number
    Eiger BioPharmaceuticals, Inc
    24-80040
    EBPI Merger Inc.
    24-80041
    EB Pharma LLC
    24-80042
    Eiger BioPharmaceuticals Europe Limited
    24-80043
    EigerBio Europe Limited
    24-80044

    Meeting of Creditors

    The Meeting of Creditors pursuant to Section 341 of the Bankruptcy Code (the "Meeting of Creditors") will be held on May 13, 2024, at 1:30 p.m. (CT). Please view the Notice of Chapter 11 Bankruptcy Case for additional information.

    Telephonic Section 341 Meeting
    Toll free number: 866−818−4670
    Alternate number: 203−480−2179
    Participant Code: 3304120

    Rule 9001(5) of the Federal Rules of Bankruptcy Procedure requires that a representative of the Debtor appear at the Meeting of Creditors for the purpose of being examined under oath by a representative of the Office of the United States Trustee and by any interested parties that attend the meeting. Creditors are welcome, but not required, to attend the meeting. The Meeting of Creditors may be continued or adjourned by notice at the meeting, without further written notice to creditors.

    Parties & Addresses


    United States Bankruptcy Court
    Northern District of Texas - Dallas Division
    Earle Cabell Federal Building
    1100 Commerce St., Rm. 1254
    Dallas, TX 75242
    T: (214) 753-2000
    http://www.txnb.uscourts.gov/


    Eiger Claims Processing Center
    c/o KCC dba Verita
    222 N. Pacific Coast Highway, Suite 300
    El Segundo, CA 90245
    T: (888) 733-1544


    Please file proof(s) of claim, if any, via US Mail or other hand delivery system. Facsimile and other electronic delivery methods are not acceptable. You must file an originally executed proof of claim. If you would like a copy of your claim returned to you as proof of receipt, please enclose an additional copy and a self-addressed postage-paid envelope.

    Attorneys' Addresses

    Thomas R. Califano
    William E. Curtin
    Anne G. Wallice
    Sidley Austin LLP
    787 Seventh Avenue
    New York, NY 10019
    T: (212) 839-5300
    F: (212) 839-5599
    https://www.sidley.com


    Charles M. Persons
    Sidley Austin LLP
    2021 McKinney Avenue, Suite 2000
    Dallas, TX 75201
    T: (214) 981-3300
    F: (214) 981-3400
    https://www.sidley.com

    Additional Links

    Eiger BioPharmaceuticals Website

    Disclaimer